tm
Seeing Is Believing
tm
Seeing Is Believing
INDP is currently covered by 2 analysts with an average price target of $17.9. This is a potential upside of $6.59 (58.27%) from yesterday's end of day stock price of $11.31.
Indaptus Therapeutics's activity chart (see below) currently has 3 price targets and 9 ratings on display. The stock rating distribution of INDP is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 70.83% with an average time for these price targets to be met of 513.5 days.
Highest price target for INDP is $5, Lowest price target is $5, average price target is $5.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 13-Nov-2024. First documented stock forecast 20-Oct-2021.
Currently out of the existing stock ratings of INDP, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$-7 (-58.33%)
$4
8 months 4 days ago
(13-Nov-2024)
2/3 (66.67%)
$3.82 (323.73%)
528
Buy
$12
9 months 1 days ago
(16-Oct-2024)
3/4 (75%)
$9.36 (354.55%)
499
What is INDP (Indaptus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on INDP (Indaptus Therapeutics) with a proven track record?
Which analyst has the current lower performing score on INDP (Indaptus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on INDP (Indaptus Therapeutics)?
Which analyst is the currently most bullish on INDP (Indaptus Therapeutics)?
Which analyst is the currently most reserved on INDP (Indaptus Therapeutics)?
